|
⚲
|
| Anterion Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001485558 |
| Sale | 2007-06-22 ($0.9 M Sold) |
| Fund | |
| Phone | 9786664406 |
| Address | 35 Congress Street Salem, 01970 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Richard Millian | |
| Jeanmarie Vallet | |
| Kim Emerling | |
| Charles Wilkinson | |
| Barry Unger | |
| Robert Leonard |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Gsp-2 Inc
✚
|
0.0 | |
|
Icahn Partners Master Fund III LP
✚
|
0.0 | |
|
Laing Diana M
✚
|
0.0 | |
|
Lifeistry LLC
✚
|
0.0 | |
|
Magor Corp
✚
|
0.0 | |
|
Langhar, Inc
✚
|
0.0 | |
|
Mehra Pankaj
✚
|
0.0 | |
|
Mitokyne, Inc.
✚
|
0.0 | |
|
Nicoya Fund LLC
✚
|
0.0 | |
|
First Growth Holdings Ltd
✚
|
0.0 |